What does N2 and N3 disease indicate in lung cancer staging for a patient with a 7 × 6 mm upper‑right pulmonary nodule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

N2/N3 Disease in Lung Cancer Staging

N2 disease indicates ipsilateral mediastinal or subcarinal lymph node involvement, while N3 disease indicates contralateral mediastinal or hilar lymph nodes, or any supraclavicular or scalene nodes on either side. 1

N Descriptor Definitions

The N staging system is based on the anatomic location of metastatic lymph nodes and follows the eighth edition TNM classification:

N2 Disease

  • Ipsilateral mediastinal lymph nodes - nodes on the same side as the primary tumor within the mediastinum 1
  • Subcarinal lymph nodes (station 7) - nodes below the carina extending to the level of origin of the left lower lobe and right middle lobe bronchus 1
  • Lymph nodes are considered abnormal when >10 mm in axial short axis diameter 1
  • The prevalence of metastatic disease is 30% for nodes 10-15 mm and 67% for nodes >15 mm 1

N3 Disease

  • Contralateral mediastinal lymph nodes - mediastinal nodes on the opposite side from the primary tumor 1
  • Contralateral hilar lymph nodes - hilar nodes on the opposite side 1
  • Any supraclavicular or scalene nodes on either side (station 1) - these extend from the lower border of the clavicles to the lower border of the cricoid 1

Clinical Significance

Prognostic Impact

  • Increasing number of involved nodal stations negatively affects prognosis 1
  • Recent data demonstrates that single-station N2 involvement (N2a) has better prognosis than multistation N2 involvement (N2b) with 5-year survival of 34% vs 20% respectively 2, 3
  • N3 disease carries significantly worse prognosis, with 5-year survival approaching 12.4% 4

Stage Grouping

  • N2 disease typically corresponds to Stage IIIA (when combined with T1-T3 tumors) 1
  • N3 disease corresponds to Stage IIIB (T1-T2N3M0) or Stage IIIC (T3-T4N3M0) in the eighth edition 1, 5

Important Caveats

Tissue confirmation is mandatory - PET-positive mediastinal findings must be histologically or cytologically confirmed before denying potentially curative surgery, as the positive predictive value of PET is only 79% 6

Axillary lymph node metastasis occurs in 0.75% of lung cancers but is not included in the N descriptor - it is considered M1 metastatic disease 1

The border between left and right paratracheal nodes is the left lateral border of the trachea, not the midline 2

For your patient with a 7 × 6 mm upper-right pulmonary nodule, this would be classified as T1a disease (tumor ≤1 cm), and accurate N staging through appropriate imaging and potential invasive staging would be critical for determining overall stage and treatment approach 1, 7.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.